Skip to content
Raise Lens
✓ Early-stage friendly

Fund I: Early-stage venture capital investing in biosolutions across alternative protein, ingredients, life sciences, and biomaterials Grant

••••• organisation

A climate venture fund based in Luxembourg

Summary

Early-stage venture capital fund investing in biosolutions companies across alternative protein, ingredients, life sciences, and biomaterials sectors, targeting the transition economy in developed markets globally. Structured as an Article 9 SFDR impact vehicle with explicit sustainability objectives.

Summary by Raise Lens from the official notice · 8 Aug 2026Accurate?

About this grant

This early-stage venture capital fund invests in biosolutions companies developing alternative proteins, ingredients, life sciences products and biomaterials. The fund targets startups and small enterprises at pre-seed, seed and Series A stages operating in developed markets globally, with a focus on companies whose work supports the transition to a sustainable economy. Investments take the form of equity. The fund is structured as an Article 9 sustainable finance vehicle with explicit sustainability objectives, meaning portfolio companies must demonstrate measurable environmental or social impact alongside commercial viability. Applicants should be prepared to show how their biosolutions address sustainability challenges within their sector.

Unlock the funder, link and full detail

Create a free account to unlock 3 full listings a month, including the funder name, the application link and the complete programme detail.

Frequently asked questions

Who can apply for Fund I: Early-stage venture capital investing in biosolutions across alternative protein, ingredients, life sciences, and biomaterials?
Eligibility covers organisations in GLOBAL; startup, sme. The full eligibility conditions are part of the Pro detail.